Processa Pharmaceuticals, Inc. PCSA Q2 2026 earnings

FAQ

When did Processa Pharmaceuticals, Inc. report Q2 2026 earnings?

Processa Pharmaceuticals, Inc. (PCSA) reported Q2 2026 earnings on August 14, 2026 before market open.

What were Processa Pharmaceuticals, Inc.'s Q2 2026 revenue and EPS?

Processa Pharmaceuticals, Inc. reported eps of $-1.19 for Q2 2026.

Did Processa Pharmaceuticals, Inc. beat estimates in Q2 2026?

EPS missed the consensus estimate of $-1.00 by $0.19.

How did Processa Pharmaceuticals, Inc.'s Q2 2026 results compare year-over-year?

Compared to the same quarter a year prior, eps declined 376.0% from $-0.25.

Where can I find Processa Pharmaceuticals, Inc.'s Q2 2026 SEC filings?

You can read the 10-Q periodic report (0001493152-26-038334) directly on SEC EDGAR. The filing index links above go to sec.gov.